<DOC>
	<DOC>NCT01315457</DOC>
	<brief_summary>The aim of this study is to propose infection prophylaxis from Asian multinational retrospective analysis of infectious complications in patients who were treated with alemtuzumab</brief_summary>
	<brief_title>Infections Associated With the Use of Alemtuzumab</brief_title>
	<detailed_description />
	<mesh_term>Alemtuzumab</mesh_term>
	<criteria>Patients received alemtuzumab as a treatment for hematologic malignancy ex. nonHodgkin lymphoma Acute myeloid leukemia Aplastic anemia Patients did not receive alemtuzumab</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>alemtuzumab, infection, prophylaxis, treatment</keyword>
</DOC>